These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21360506)

  • 1. The NZM2410-derived lupus susceptibility locus Sle2c1 increases Th17 polarization and induces nephritis in fas-deficient mice.
    Xu Z; Cuda CM; Croker BP; Morel L
    Arthritis Rheum; 2011 Mar; 63(3):764-74. PubMed ID: 21360506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic dissection of the murine lupus susceptibility locus Sle2: contributions to increased peritoneal B-1a cells and lupus nephritis map to different loci.
    Xu Z; Duan B; Croker BP; Wakeland EK; Morel L
    J Immunol; 2005 Jul; 175(2):936-43. PubMed ID: 16002692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin-dependent kinase inhibitor Cdkn2c deficiency promotes B1a cell expansion and autoimmunity in a mouse model of lupus.
    Potula HH; Xu Z; Zeumer L; Sang A; Croker BP; Morel L
    J Immunol; 2012 Sep; 189(6):2931-40. PubMed ID: 22896639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology.
    Kikawada E; Lenda DM; Kelley VR
    J Immunol; 2003 Apr; 170(7):3915-25. PubMed ID: 12646661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combination of two Sle2 lupus-susceptibility loci and Cdkn2c deficiency leads to T-cell-mediated pathology in B6.Fas(lpr) mice.
    Xu Z; Croker BP; Morel L
    Genes Immun; 2013 Sep; 14(6):373-9. PubMed ID: 23698709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The centromeric region of chromosome 7 from MRL mice (Lmb3) is an epistatic modifier of Fas for autoimmune disease expression.
    Kong PL; Morel L; Croker BP; Craft J
    J Immunol; 2004 Mar; 172(5):2785-94. PubMed ID: 14978078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative role of colony-stimulating factor-1 in macrophage, T cell, and B cell mediated autoimmune disease in MRL-Fas(lpr) mice.
    Lenda DM; Stanley ER; Kelley VR
    J Immunol; 2004 Oct; 173(7):4744-54. PubMed ID: 15383612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of receptor for advanced glycation end products exacerbates lymphoproliferative syndrome and lupus nephritis in B6-MRL Fas lpr/j mice.
    Goury A; Meghraoui-Kheddar A; Belmokhtar K; Vuiblet V; Ortillon J; Jaisson S; Devy J; Le Naour R; Tabary T; Cohen JH; Schmidt AM; Rieu P; Touré F
    J Immunol; 2015 Apr; 194(8):3612-22. PubMed ID: 25762779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine lupus susceptibility locus Sle2 activates DNA-reactive B cells through two sub-loci with distinct phenotypes.
    Zeumer L; Sang A; Niu H; Morel L
    Genes Immun; 2011 Apr; 12(3):199-207. PubMed ID: 21270826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Function of the Th17/interleukin-17A immune response in murine lupus nephritis.
    Schmidt T; Paust HJ; Krebs CF; Turner JE; Kaffke A; Bennstein SB; Koyro T; Peters A; Velden J; Hünemörder S; Haag F; Steinmetz OM; Mittrücker HW; Stahl RA; Panzer U
    Arthritis Rheumatol; 2015 Feb; 67(2):475-87. PubMed ID: 25385550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice.
    Schwarting A; Wada T; Kinoshita K; Tesch G; Kelley VR
    J Immunol; 1998 Jul; 161(1):494-503. PubMed ID: 9647261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cathepsin K Deficiency Ameliorates Systemic Lupus Erythematosus-like Manifestations in
    Zhou Y; Chen H; Liu L; Yu X; Sukhova GK; Yang M; Kyttaris VC; Stillman IE; Gelb B; Libby P; Tsokos GC; Shi GP
    J Immunol; 2017 Mar; 198(5):1846-1854. PubMed ID: 28093526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant macrophages mediate defective kidney repair that triggers nephritis in lupus-susceptible mice.
    Iwata Y; Boström EA; Menke J; Rabacal WA; Morel L; Wada T; Kelley VR
    J Immunol; 2012 May; 188(9):4568-80. PubMed ID: 22467656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of reciprocal Lmb1-4 interval MRL-Faslpr and C57BL/6-Faslpr congenic mice reveals significant effects from Lmb3.
    Santiago-Raber ML; Haraldsson MK; Theofilopoulos AN; Kono DH
    J Immunol; 2007 Jun; 178(12):8195-202. PubMed ID: 17548658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential role of three major New Zealand Black-derived loci linked with Yaa-induced murine lupus nephritis.
    Kikuchi S; Fossati-Jimack L; Moll T; Amano H; Amano E; Ida A; Ibnou-Zekri N; Laporte C; Santiago-Raber ML; Rozzo SJ; Kotzin BL; Izui S
    J Immunol; 2005 Jan; 174(2):1111-7. PubMed ID: 15634937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piperlongumine alleviates lupus nephritis in MRL-Fas(lpr) mice by regulating the frequency of Th17 and regulatory T cells.
    Yao L; Chen HP; Ma Q
    Immunol Lett; 2014 Sep; 161(1):76-80. PubMed ID: 24837470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of peritoneal B-1a cells accumulation induced by murine lupus susceptibility locus Sle2.
    Xu Z; Butfiloski EJ; Sobel ES; Morel L
    J Immunol; 2004 Nov; 173(10):6050-8. PubMed ID: 15528340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-10 regulation of lupus in the NZM2410 murine model.
    Blenman KR; Duan B; Xu Z; Wan S; Atkinson MA; Flotte TR; Croker BP; Morel L
    Lab Invest; 2006 Nov; 86(11):1136-48. PubMed ID: 16924244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of activated lymphocyte-derived DNA accelerates and aggravates lupus nephritis in B6/lpr mice: a new approach to modify a lupus murine model.
    Zhu Y; Yue Y; Xiong S
    Clin Exp Immunol; 2018 Sep; 193(3):302-312. PubMed ID: 29704464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of
    Hiramatsu-Asano S; Sunahori-Watanabe K; Zeggar S; Katsuyama E; Mukai T; Morita Y; Wada J
    Front Immunol; 2020; 11():616141. PubMed ID: 33574820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.